MediPharm Labs Corp (MEDIF)
0.0628
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
MediPharm Labs Price to Book Value: 0.6351 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.6351 |
| May 02, 2024 | 0.6146 |
| May 01, 2024 | 0.6306 |
| April 30, 2024 | 0.6927 |
| April 29, 2024 | 0.568 |
| April 26, 2024 | 0.6371 |
| April 25, 2024 | 0.6036 |
| April 24, 2024 | 0.6088 |
| April 23, 2024 | 0.5884 |
| April 22, 2024 | 0.5663 |
| April 19, 2024 | 0.5623 |
| April 18, 2024 | 0.5764 |
| April 17, 2024 | 0.5855 |
| April 16, 2024 | 0.6027 |
| April 15, 2024 | 0.5784 |
| April 12, 2024 | 0.5835 |
| April 11, 2024 | 0.6067 |
| April 10, 2024 | 0.6351 |
| April 09, 2024 | 0.6523 |
| April 08, 2024 | 0.6371 |
| April 05, 2024 | 0.6816 |
| April 04, 2024 | 0.647 |
| April 03, 2024 | 0.6265 |
| April 02, 2024 | 0.6356 |
| April 01, 2024 | 0.6517 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.6391 |
| March 27, 2024 | 0.629 |
| March 26, 2024 | 0.6765 |
| March 25, 2024 | 0.6128 |
| March 22, 2024 | 0.5867 |
| March 21, 2024 | 0.4923 |
| March 20, 2024 | 0.5023 |
| March 19, 2024 | 0.4958 |
| March 18, 2024 | 0.5023 |
| March 15, 2024 | 0.4848 |
| March 14, 2024 | 0.4742 |
| March 13, 2024 | 0.4973 |
| March 12, 2024 | 0.4892 |
| March 11, 2024 | 0.5023 |
| March 08, 2024 | 0.4946 |
| March 07, 2024 | 0.5058 |
| March 06, 2024 | 0.5038 |
| March 05, 2024 | 0.4935 |
| March 04, 2024 | 0.4822 |
| March 01, 2024 | 0.4782 |
| February 29, 2024 | 0.4953 |
| February 28, 2024 | 0.4762 |
| February 27, 2024 | 0.5023 |
| February 26, 2024 | 0.5083 |
| February 23, 2024 | 0.5154 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2294
Minimum
Jun 13 2022
21.51
Maximum
May 17 2019
1.812
Average
0.6927
Median
Apr 30 2024
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4302 |
| Aurinia Pharmaceuticals Inc | 1.930 |
| Edesa Biotech Inc | 2.514 |
| Lexaria Bioscience Corp | 6.185 |
| Xenon Pharmaceuticals Inc | 3.558 |
Price to Book Value Related Metrics
| PS Ratio | 1.013 |
| Price | 0.0628 |
| Earnings Yield | -47.17% |
| Market Cap | 25.37M |